StonvexLoading…
StonvexStonvexStonvexCore line items from CNTY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $572.98M | $575.92M | $550.21M | $430.53M |
Operating Income | $51.28M | $-22.16M | $64.05M | $67.61M |
Net Income | $-61.42M | $-153.60M | $-28.20M | $7.98M |
EPS (Diluted) | $-2.04 | $-5.02 | $-0.93 | $0.25 |
Total Assets | $1.15B | $1.20B | $1.36B | $884.97M |
Total Liabilities | $1.15B | $1.14B | $1.15B | $730.77M |
Cash & Equivalents | $68.92M | $98.77M | $171.33M | $101.78M |
Free Cash Flow OCF − CapEx | $-15.26M | $-62.53M | $-35.57M | $18.20M |
Shares Outstanding | 28.73M | 30.68M | 30.36M | 29.87M |